Eric Richier is the Head of the Microbiology Platform within Global Analytical Sciences at Sanofi, specializing in Vaccine CMC Development and Supply. With over 20 years of experience in biologics R&D, they have held significant roles including Biologics Expert Scientist at Virbac S.A. and Senior Scientist at Sanofi. Eric began their academic journey with a degree in Chemistry from Université Côte d'Azur and earned a PhD in Pharmaceutical and Biological Sciences from CBS2. They have led various scientific projects, including the development of vaccines for market authorization.
This person is not in the org chart
This person is not in any teams
This person is not in any offices